Melamine contamination in nutritional supplements--Is it an alarm bell for the general consumer, athletes, and 'Weekend Warriors'?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101152213 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2891 (Electronic) Linking ISSN: 14752891 NLM ISO Abbreviation: Nutr J Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, 2002-
    • Subject Terms:
      Consumer Product Safety/*standards ; Dietary Supplements/*standards ; Food Contamination/*analysis ; Triazines/*analysis ; Triazines/*toxicity; Animal Feed/analysis ; Athletes ; China ; Humans ; No-Observed-Adverse-Effect Level ; South Africa ; Triazines/standards ; World Health Organization
    • Abstract:
      Background: Nutritional supplements are used or experimented with by consumers, notably these are; competitive and recreational athletes of all ages, and 'weekend warriors'. As a consequence the supplement industry has grown to meet the increasing demand. A Global Industry Analysts Inc. report indicates that the herbal supplement market has not declined during the worldwide recession, but in fact exhibited steady growth over the period 2008 to 2009. It is anticipated that the market will reach US$93.15 billion by the year 2015. These supplements may contain adulterated substances that may potentially have harmful short - and long-term health consequences to the consumer. "Scrap Melamine" is such an example, which has been implicated in the kidney failure and death of several cats, dogs and pigs. In China in 2008, reports described very severe health effects in infants and young children. At the time over 294,000 infants were screened and diagnosed with urinary tract stones and sand-like calculi associated with melamine in milk products, of which 50,000 infants were hospitalised, and at least six associated deaths, recorded. The extent that melamine contamination occurs in nutritional supplements is not known. Therefore, the aim of this study was to determine whether commercially available nutritional and traditional supplement products contain melamine, even though they are not declared by the manufacturer on the product label.
      Methods: A total of 138 nutritional supplements products were obtained from (i) direct purchases from shops, pharmacies and outlets, (ii) directly from consumers, and (iii) from suppliers, manufacturers and distributors. The products were laboratory analysed for melamine, using Tandem Liquid Chromatography Mass Spectrometry.
      Results: Forty-seven % of all the products (n = 138) tested positive for melamine. Eight-two % of the South African produced products (n = 27) tested positive and 58 % of the products imported into South Africa (n = 50) tested positive. The median concentration estimate for melamine in the products tested were, 6.0 μg/g for the 138 supplements tested, 8.9 μg/g for South African produced products, and 6.9 μg/g for products imported into South Africa.
      Conclusion: The melamine (undeclared on product label) levels detected in the nutritional supplements products investigated were within the Tolerable Daily intake (TDI) limit guidelines of 200 μg/g as set by WHO and others. Melamine over exposure within the context of the nutritional supplements consumption in the products investigated should not be of concern to the consumer provided the recommended guidelines of daily product use are adhered to. Further investigation is warranted to determine, (i) the link of melamine as (part) substitute for the perceived total declared protein content on the product label, (ii) cyanuric and uric acid presence in the supplement products that could form chemical-complex formation with melamine and/or analogues that could cause adverse health effects.
    • References:
      Regul Toxicol Pharmacol. 2009 Oct;55(1):13-6. (PMID: 19486917)
      Food Chem Toxicol. 2008 Mar;46(3):1196-200. (PMID: 18166259)
      Regul Toxicol Pharmacol. 2010 Mar;56(2):193-6. (PMID: 19788907)
      Biomed Environ Sci. 2009 Apr;22(2):95-9. (PMID: 19618684)
      Environ Health Perspect. 2009 Dec;117(12):1803-8. (PMID: 20049196)
      Clin Chim Acta. 2013 May;420:128-33. (PMID: 23089071)
      Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2542-6. (PMID: 20435082)
      Food Chem. 2010 Aug 1;121(3):912-917. (PMID: 20228949)
      Clin Chim Acta. 2010 Feb;411(3-4):184-9. (PMID: 19900434)
      Toxicol In Vitro. 2013 Sep;27(6):1603-11. (PMID: 23643631)
      Toxicol Lett. 2012 Aug 3;212(3):307-14. (PMID: 22688180)
      Reprod Toxicol. 2013 Jan;35:40-7. (PMID: 22732147)
      Nutrition. 2014 Apr;30(4):380-5. (PMID: 24206822)
      Environ Int. 2010 Jul;36(5):446-52. (PMID: 20385408)
      Anal Chim Acta. 2009 Sep 1;649(1):91-7. (PMID: 19664467)
      Clin Chim Acta. 2009 Apr;402(1-2):150-5. (PMID: 19171128)
      S Afr Med J. 2010 Aug;100(8):494-7. (PMID: 20822613)
      Clin Chim Acta. 2014 Mar 20;430:96-103. (PMID: 24418618)
      Food Chem Toxicol. 2012 Dec;50(12):4389-97. (PMID: 22963836)
    • Accession Number:
      0 (Triazines)
      N3GP2YSD88 (melamine)
    • Publication Date:
      Date Created: 20150718 Date Completed: 20160325 Latest Revision: 20181113
    • Publication Date:
      20240104
    • Accession Number:
      PMC4504043
    • Accession Number:
      10.1186/s12937-015-0055-7
    • Accession Number:
      26182916